Comerica (CMA) Stock Forecast & Price Target $59.08 +0.36 (+0.61%) Closing price 03/31/2025 03:59 PM EasternExtended Trading$59.06 -0.02 (-0.03%) As of 08:38 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Analyst Forecasts Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Comerica - Analysts' Recommendations and Stock Price Forecast (2025) How MarketBeat Calculates Price Target and Consensus Rating MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. Consensus Rating HoldBased on 22 Analyst RatingsSell3Hold12Buy7 Based on 22 Wall Street analysts who have issued ratings for Comerica in the last 12 months, the stock has a consensus rating of "Hold." Out of the 22 analysts, 3 have given a sell rating, 12 have given a hold rating, and 7 have given a buy rating for CMA. Consensus Price Target $67.6214.46% Upside According to the 22 analysts' twelve-month price targets for Comerica, the average price target is $67.62. The highest price target for CMA is $80.00, while the lowest price target for CMA is $52.00. The average price target represents a forecasted upside of 14.46% from the current price of $59.08. Get the Latest News and Ratings for CMA and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Comerica and its competitors. Enter your email to sign up for newsletter Sign Up CMA Analyst Ratings Over TimeTypeCurrent Forecast4/1/24 to 4/1/251 Month Ago3/2/24 to 3/2/253 Months Ago1/2/24 to 1/1/251 Year Ago4/2/23 to 4/1/24Strong Buy0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)Buy7 Buy rating(s)8 Buy rating(s)9 Buy rating(s)6 Buy rating(s)Hold12 Hold rating(s)11 Hold rating(s)11 Hold rating(s)13 Hold rating(s)Sell3 Sell rating(s)3 Sell rating(s)3 Sell rating(s)2 Sell rating(s)Consensus Price Target$67.62$68.57$67.68$56.93Forecasted Upside14.46% Upside6.64% Upside9.43% Upside5.23% UpsideConsensus RatingHoldHoldHoldHold Remove Ads CMA Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History CMA Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table Comerica Stock vs. The CompetitionTypeComericaFinance CompaniesS&P 500Consensus Rating Score 2.18 2.53 2.54Consensus RatingHoldModerate BuyModerate BuyPredicted Upside14.46% Upside49.52% Upside19.04% UpsideNews Sentiment RatingNeutral NewsSee Recent CMA NewsPositive NewsPositive News Remove Ads Recent Analyst Forecasts and Stock Ratings All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Years 5 Years Time Frame Start Date End Date Most Recent from Each Brokerage All Show Export to Excel DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails3/31/2025Stephens4 of 5 starsTerry McEvoySubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeOverweight ➝ Equal Weight$66.00 ➝ $64.00+8.97%3/28/2025Wells Fargo & Company3 of 5 starsM. MayoSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower TargetEqual Weight ➝ Equal Weight$70.00 ➝ $67.00+14.52%3/13/2025Morgan Stanley3 of 5 starsManan GosaliaSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower TargetEqual Weight ➝ Equal Weight$71.00 ➝ $63.00+9.67%2/11/2025Robert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy ratingDavid GeorgeSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost TargetOutperform ➝ Outperform$75.00 ➝ $80.00+20.78%1/31/2025ArgusSubscribe to MarketBeat All Access for the recommendation accuracy ratingK. HealSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold1/23/2025Royal Bank of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingKarl ShepardSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower TargetOutperform ➝ Outperform$78.00 ➝ $76.00+20.02%1/23/2025DA DavidsonSubscribe to MarketBeat All Access for the recommendation accuracy ratingPeter WinterSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower TargetNeutral ➝ Neutral$71.00 ➝ $67.00+6.83%1/23/2025Keefe, Bruyette & WoodsSubscribe to MarketBeat All Access for the recommendation accuracy ratingC. McgrattySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower TargetOutperform ➝ Outperform$82.00 ➝ $77.00+22.74%1/7/2025JPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy rating Lower TargetNeutral ➝ Neutral$73.00 ➝ $70.00+11.73%1/7/2025The Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingR. NashSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Neutral$85.00 ➝ $71.00+12.56% Get the Latest News and Ratings for CMA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Comerica and its competitors with MarketBeat's FREE daily newsletter. 1/6/2025Truist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingB. KingSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold1/6/2025BarclaysSubscribe to MarketBeat All Access for the recommendation accuracy rating Boost TargetUnderweight ➝ Underweight$66.00 ➝ $68.00+7.09%12/17/2024UBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingE. NajarianSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageNeutral ➝ Sell$60.00 ➝ $64.00-1.37%12/10/2024Compass PointSubscribe to MarketBeat All Access for the recommendation accuracy rating Boost TargetBuy ➝ Buy$64.00 ➝ $80.00+18.13%12/3/2024Piper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy rating Boost TargetNeutral ➝ Neutral$64.00 ➝ $72.00+1.35%10/30/2024Evercore ISISubscribe to MarketBeat All Access for the recommendation accuracy rating Boost TargetIn-Line ➝ In-Line$64.00 ➝ $69.00+7.04%10/7/2024Bank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy rating DowngradeNeutral ➝ Underperform$55.00 ➝ $52.00-11.65%9/24/2024WedbushSubscribe to MarketBeat All Access for the recommendation accuracy ratingD. ChiaveriniSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeNeutral ➝ Outperform$52.00 ➝ $75.00+24.61%7/2/2024Raymond JamesSubscribe to MarketBeat All Access for the recommendation accuracy ratingM. RoseSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeMarket Perform ➝ Outperform$60.00+18.11%5/6/2024CitigroupSubscribe to MarketBeat All Access for the recommendation accuracy rating DowngradeBuy ➝ Neutral$60.00 ➝ $56.00+5.52%4/10/2024Deutsche Bank AktiengesellschaftSubscribe to MarketBeat All Access for the recommendation accuracy rating Initiated CoverageHold$59.00+8.30%4/8/2024Jefferies Financial GroupSubscribe to MarketBeat All Access for the recommendation accuracy rating Lower TargetBuy ➝ Buy$65.00 ➝ $60.00+10.76%1/18/2024Bank Of America (Bofa)Subscribe to MarketBeat All Access for the recommendation accuracy rating Boost TargetNeutral ➝ Neutral$52.00 ➝ $55.00+5.95%9/26/2023Odeon Capital GroupSubscribe to MarketBeat All Access for the recommendation accuracy rating DowngradeBuy ➝ Hold$46.00+11.03%6/29/202358.comSubscribe to MarketBeat All Access for the recommendation accuracy rating Reiterated RatingMaintains5/3/2023Wolfe ResearchSubscribe to MarketBeat All Access for the recommendation accuracy rating DowngradeOutperform ➝ Peer PerformAnalyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 08:44 AM ET. CMA Forecast - Frequently Asked Questions What is Comerica's forecast for 2025? According to the research reports of 22 Wall Street equities research analysts, the average twelve-month stock price forecast for Comerica is $67.62, with a high forecast of $80.00 and a low forecast of $52.00. Should I buy or sell Comerica stock right now? 22 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Comerica in the last year. There are currently 3 sell ratings, 12 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" CMA shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CMA, but not buy additional shares or sell existing shares. Does Comerica's stock price have much upside? According to analysts, Comerica's stock has a predicted upside of 14.46% based on their 12-month stock forecasts. Has Comerica been upgraded or downgraded by Wall Street analysts recently? Over the previous 90 days, Comerica's stock had 2 upgrades and 2 downgrades by analysts. What analysts cover Comerica? Comerica has been rated by research analysts at Argus, Barclays, DA Davidson, JPMorgan Chase & Co., Keefe, Bruyette & Woods, Morgan Stanley, Robert W. Baird, Royal Bank of Canada, Stephens, The Goldman Sachs Group, Truist Financial, and Wells Fargo & Company in the past 90 days. Do Wall Street analysts like Comerica more than its competitors? Analysts like Comerica less than other "finance" companies. The consensus rating for Comerica is Hold while the average consensus rating for "finance" companies is Moderate Buy. Learn more on how CMA compares to other companies. Stock Forecasts and Research Tools Related Companies BLX Stock Forecast WFC Stock Forecast USB Stock Forecast HBAN Stock Forecast RF Stock Forecast KEY Stock Forecast FHN Stock Forecast WBS Stock Forecast PNFP Stock Forecast CFR Stock Forecast Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter This page (NYSE:CMA) was last updated on 4/1/2025 by MarketBeat.com Staff From Our PartnersNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredNew “Trump” currency proposed in DCA former U.S. Presidential Advisor has come forward with a stern warning to investors: “Get out of tech, no...Paradigm Press | SponsoredIs Fort Knox Hiding Less Gold Than We Think? Find Out What That Means for YouWith gold prices recently soaring to record highs over $3,000 an ounce, and central banks rushing to accumulat...The Oxford Club | SponsoredLive Footage From Elon Musk’s “Area 51”What’s happening inside this nondescript building in South Memphis is so incredible… That Elon’s competitor...Brownstone Research | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredTermination: 18F (read immediately)Have you ever heard of the government's 18F program? It helped manage digital services across the governmen...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Comerica Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Comerica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CMA Stock Free CMA Stock Alerts